| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |